Sharemaestro Newsreel

STERIS (STE) Could Be 10% Undervalued Following Strong Results And $600 Million Expansion

QuidelOrtho (QDEL) Stock Sees Fair Value Cut As Analysts Rework Growth Expectations

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The sharp reset in QuidelOrtho's fair value estimate from US$20.50 to US$12.00 per share sits alongside analyst price targets that now cluster around the US$12 …

Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical has seen its assessed fair value cut from US$107.42 to US$103.23, a modest 3.9% trim that reflects a cooler view on …

Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

The Rosen Law Firm reminds investors who purchased Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025, and May 26, 2026, of the August 31, 2026, lead plaintiff deadline for a securities fraud lawsuit. The lawsuit alleges that Insulet made false and misleading statements …

Is Globus Medical (GMED) A Bargain On Its Zacks Upgrade And Reaffirmed Guidance?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Globus Medical (GMED) has been in focus after a recent upgrade to Zacks Rank #1, which came shortly after the company reaffirmed its …

The 5 Most Interesting Analyst Questions From Bruker’s Q2 Earnings Call

The 5 Most Interesting Analyst Questions From Bruker's Q2 Earnings Call Bruker's second quarter results prompted a significant negative market reaction, with shares declining sharply following the release. Management identified several factors behind the top-line shortfall, notably the ongoing weakness in U.S. academic and …

908 Devices Inc (MASS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...

908 Devices Inc. (MASS) reported strong Q2 2026 results with a 23% revenue increase to $16.1 million, driven by demand from US state and local customers. The company significantly improved profitability, cutting adjusted EBITDA loss by over 50% year-over-year, and raised its full-year 2026 …

(SIBN) and the Role of Price-Sensitive Allocations

This article provides a quantitative analysis of Si-bone Inc. (NASDAQ: SIBN), highlighting strong near and mid-term sentiment which could extend long-term, and notes compelling upside potential due to the absence of upper resistance levels. It outlines three AI-generated trading strategies with specific entry, target, …

Chemed Corp (CHE) Stock Forecasts

Argus has lowered its target price for Chemed Corp (CHE) to $564.00, citing the company's business activities of purchasing, operating, and divesting subsidiaries to maximize shareholder value. As of the report date, Chemed Corp's current price is $540.25. The report suggests upgrading to premium …

Cytek (CTKB) Q2 2026 Earnings Call Transcript

Christopher Brown Sells 8,358 Shares of 908 Devices (NASDAQ:MASS) Stock

908 Devices Director Christopher Brown sold 8,358 shares of the company's stock for $77,144, reducing his ownership by 1.03%. This sale occurred under a pre-arranged Rule 10b5-1 plan. The company recently reported better-than-expected quarterly revenue and adjusted EPS, and raised the lower end of …

Insulet Corporation Investors With Significant Losses Must Act By August 31, 2026

Kirby McInerney LLP reminds Insulet Corporation (NASDAQ: PODD) investors with significant losses that the deadline to seek the role of lead plaintiff in a federal securities class action is August 31, 2026. The lawsuit alleges Insulet made misleading public statements regarding defective manufacturing controls …

QT Imaging Holdings affirms $39.000M FY26 sales guidance

QT Imaging Holdings (NASDAQ: QTI) has reaffirmed its FY26 sales guidance at $39.000 million, which is consistent with prior reports but $0.200 million below the analyst consensus of $39.200 million. This stable guidance indicates a consistent operational outlook for the company, despite a slight …

Nortech Systems Q2 sales up 9%, EPS falls 8% on higher operating costs

Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)

LivaNova PLC recently reported second-quarter 2026 results showing sales rising to US$390.59 million and net income climbing to US$108.57 million, alongside higher earnings per share versus a year earlier. On the back of this performance, the company raised its 2026 constant-currency revenue growth guidance …

Butterfly Network CEO Joseph DeVivo Sells 68,346 Shares via Rule 10b5-1 Plan

Butterfly Network CEO Joseph DeVivo sold 68,346 shares of Class A Common Stock on August 10, 2026, for a weighted average price of $10.009 per share. This transaction was conducted under a pre-established Rule 10b5-1 trading plan adopted in December 2025. Following the sale, …

Artivion SVP Jean Holloway sells 977 shares for $27,834

Jean F. Holloway, SVP at Artivion Inc. (NASDAQ:AORT), sold 977 shares for $27,834 at $28.49 per share. This transaction occurred after the stock saw a 9.4% gain over the past week, and Holloway now directly holds 184,118 shares. The company recently reported strong Q2 …

Jean Holloway Sells 977 Shares of Artivion (NYSE:AORT) Stock

Jean Holloway, SVP of Artivion (NYSE:AORT), sold 977 shares of the company's stock for a total of $27,834.73, reducing her direct ownership to 184,118 shares. This transaction occurred as Artivion reported strong quarterly earnings, exceeding revenue estimates, and maintains a "Moderate Buy" consensus rating …

MaxCyte (NASDAQ:MXCT) Issues Earnings Results

MaxCyte (NASDAQ:MXCT) reported a slight beat on earnings with an adjusted loss of $0.08 per share against an expected $0.09 loss, and revenue of $6.5 million, largely meeting estimates. The company reaffirmed its 2026 revenue guidance of $30 million–$32 million, anticipating instrument placements to …

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

Haemonetics Corp (HAE) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 77/100

Haemonetics Corp (HAE) shares increased by 4.7% to $91.34, approaching its 52-week high, with significant short-term and long-term momentum. Despite this rise, GuruFocus's GF Value™ indicates the stock is overvalued by 7.6% compared to its estimate of $84.90, suggesting no margin of safety for …

Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs

Sean F. Scanlan, Chief Innovation Officer at Treace Medical Concepts (TMCI), reported a Form 4 transaction indicating the disposition of 9,814 shares of common stock. These shares were delivered or withheld to cover exercise price or tax liability. Following this transaction, Scanlan directly holds …

Cytek Biosciences (CTKB) awards 241,416 RSUs and 127,118 options to top lawyer

Cytek Biosciences (CTKB) has granted new equity awards to its Chief Legal Officer and Secretary, Ilan Feuchtwang. These awards include 241,416 Restricted Stock Units (RSUs) and an option to purchase 127,118 shares of common stock at an exercise price of $4.66 per share. Both …

Lucid Diagnostics (NASDAQ:LUCD) Issues Earnings Results, Misses Estimates By $0.04 EPS

Lucid Diagnostics (NASDAQ:LUCD) reported a Q2 loss of $0.08 per share, missing analyst estimates by $0.04, despite revenue of $1.47 million which slightly exceeded expectations. Shares rose 1.9% following the announcement but remain near their 12-month low. Insider buying was noted, with Director Dennis …

Earnings call transcript: Sera Prognostics misses Q2 2026 estimates as growth builds

Butterfly Network Deputy General Counsel Nicholas Caezza Sells 10,000 Shares at $9.75 Each

Nicholas Caezza, Deputy General Counsel of Butterfly Network, Inc., sold 10,000 shares of Class A Common Stock on August 11, 2026, at a price of $9.75 per share. Following this transaction, Caezza directly holds 300,307 Class A Common Stock shares. The sale was reported …

LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record …

Lumexa Imaging Holdings Reports Q2 2026 Financial Results in SEC 8-K Filing

Lumexa Imaging Holdings, Inc. filed an 8-K report with the SEC on August 12, 2026, announcing its financial results for the quarter ended June 30, 2026. The report includes a press release (Exhibit 99.1) detailing the results of operations and financial condition, as well …

Sera Prognostics earnings missed by $0.03, revenue fell short of estimates

Accuray names two executives to lead transformation efforts

Accuray Incorporated has announced the appointment of Todd Brown as Senior Vice President for a new Enterprise Performance Optimization organization and Sofiane Laoussadi as Senior Vice President, Global Services & Solutions. These appointments are part of the company's "Transformation Phase II" priorities, aimed at …

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

AxoGen (NASDAQ:AXGN) EVP Marc Began Sells 67,500 Shares of Stock

AxoGen EVP Marc Began sold 67,500 shares of company stock for approximately $3.20 million, reducing his direct holdings by over 57%. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan. Despite the insider sale, AxoGen shares rose, nearing their 52-week high, and …

AxoGen (NASDAQ:AXGN) Director Sells $646,552.26 in Stock

AxoGen Director Amy McBride Wendell sold 13,353 shares of AXGN stock for over $646,000, reducing her total holdings by 11.01%. This sale occurred under a pre-arranged Rule 10b5-1 plan, and comes as AxoGen shares traded up 2.5% to $49.67, near their 52-week high, following …

Accuray (NASDAQ: ARAY) seeks approval for $55M recapitalization, dilution and reverse split

Accuray (NASDAQ: ARAY) is seeking stockholder approval for a significant financing and recapitalization plan, including issuing $55 million in Series A Convertible Preferred Stock and warrants, and a reverse stock split. The plan aims to strengthen liquidity, reduce leverage, and achieve Nasdaq compliance, but …

FEED Looks 91.4% Undervalued on GF Value™ Despite Distressed Fundamentals

ENvue Medical Inc (NASDAQ: FEED) announced a $50 million equity facility to enhance its ENvue feeding tube navigation system and explore new technologies, despite a nearly 10% pre-market share drop. The company's GF Value™ suggests it is 91.4% undervalued, yet its GF Score™ of …

Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Misses Revenue Estimates